0HOY trade ideas
Boston Scientific Receives FDA Clearance for EXALT™ Model B SingBSX: Boston Scientific Corporation
2021-08-10 16:00:00
Boston Scientific Receives FDA Clearance for EXALT™ Model B Single-Use Bronchoscope
BSX w 24 2021. Open Long to 78.Weekly
Stable uptrend + bullish sector
Cup and Handle formation
Will be break out to UP.
Better to pick Long now
Daily
Uptrend
I think company worth to buy now.
It has very good potential to double assets before 2024.
When CUP and Handle Formation will be finished.
Open 43
SL 25
TP 78
RR 3,5
$BSX Making a Run for R2-Analyst PT $49
-Beat last 3 out 4 last ERs
-Has been on an uptrend Since Jan 2021
-Very nice W pattern formation
-Bouncing off S1 before it makes a run for R1 and then R2
-Bernstein Conference on June 4th
- Unusual $OPT Activity as well, will send out alert
BSX: A name to remember. Must have in the portfolio.This is on a monthly. Gigantic Cup and Handle formation and upcoming earnings. Deadly combo. Near term prices marked.
gl
$BSX bear trap played out - watch or start to get inBSX has just finished a pretty nice bear trap. I started a initial position, and will fully get in if the price broke through $40 pivot line. If you look at the weekly or even monthly graph, you can see a 16-year huge cup and handle forming. Expect huge up-side to play out in 2021 or 2022. If you want to buy call, buy 2023 leaps.
$BSX with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BSX after a Negative over reaction following its earnings release placing the stock in drift C
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
BSX Long In Wedge consolidation
Volume went done
SMA50/200 as Support
Entry 38.7
Stop 36.7
Target 46
I am not a PRO trader. I trade option to test my trading plan with small cost.
The max Risk of each plan is less than 1% of my account.
If you like this idea, please use SIM/Demo account to try it.
downtrend resistance coming into play!could see some more green, but the upside is limited if it keeps bouncing down from the trendline resistance.. bullish if trendline breaks though! for now i think we should look at the 35-36 area for a dip entry! goodluck guys :)
Long #BSXNYSE:BSX
From a technical standpoint #BSX is reporting a divergence between RSI and Price, in addition the MACD is sloping up leading us to think that a move to the upside is imminent.
The MACD, still below 0, correctly describe the negative momentum: we expect for the near future to retest the upper end of the downward channel at $ 36.50.
Buy price: $ 33.69
1st target: $ 35.00
2nd target: $ 36.00
Stop loss: $ 32.80
Achat BOSTON SCIENTIFICJ'achète ce titre sur le support qui fait le job
TipRanks target : 43$
je vies 42.20$
BSX LongDemand Zone below Sideway Consolidation
Entry 34.5
Stop 32.5
target: 42;
I am not a PRO trader. I need few months to practice trading strategies.
If you like this idea, please use SIM/Demo account to try it, until my trading plans get high winning rate.
Boston Scientific Receives FDA Approval for the Ranger(TM) Drug-BSX: Boston Scientific Corporation
2020-11-02 09:41:00
Boston Scientific Receives FDA Approval for the Ranger(TM) Drug-Coated Balloon
BSX-0.81*XRAY $BSX(Boston Scientific) vs. $XRAY(Dentsply Sirona)Quantamental Tools for Proprietary and Retail Investors.
Statistical Arbitrage Opportunities Delivered to Your Inbox.
QuantChart. io
Long 100 $BSX
Short 81 $XRAY
Mean Reversion Time: 8 Trading Days
daily analysis of BOSTON SCIENTIFIC Hi friends
the daily chart shows that it will experience a downtrend with a high probability so I recommend not to buy this stock next Monday
but from Tuesday if it has not passed the level of 41.30 do not enter a buyer because in general the weekly chart shows that it will experience a downtrend
cordially
BOSTON SCIENTIFIC DAILY ANALYSISHi friends
the daily chart of this market shows with a high probability that it will experience an uptrend in the next few days but it is better to be vigilant of the change in this market towards the opposite direction
please subscribe to receive more analysis
BSX breakout and resistance levelKeep watching if this moves up or back down, especially after earnings
Boston Scientific Receives FDA Approval for Next-Generation WATCBSX: Boston Scientific Corporation
2020-07-21 16:24:00
Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device
Bullish Charts - Golden CrossBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Daily Chart - Golden Cross
Stochastic is moving up, Bullish
RSI is crossing center line, Bullish
Volume just went green on the daily
I think the stock is getting ready to move higher.
I also think, BSX is one of the cheapest medical device companies in the industry.
Long
